everytraceeverytraceeverytraceeverytrace
all names

International Normalized Ratio organisation

Named in 1 report across 1 story - 22 Sept

The web around International Normalized Ratio

Closest companions, sized by how often they share a report with International Normalized Ratio. Lines between the outer names are their own relationships - names that appear together even without International Normalized Ratio.

European Society For Medical Oncology and Exchange Commission share 1 reportAccess Program and Madrid share 1 reportAccess Program and European Society For Medical Oncology share 1 reportEuropean Society For Medical Oncology and Japanese share 1 reportArcotatug Tavatecan and Madrid share 1 reportArcotatug Tavatecan and Japanese share 1 reportAccess Program and Japan share 1 reportJapan and Japanese share 1 reportJapan and Madrid share 1 reportArcotatug Tavatecan and Christopher Oreilly share 1 reportChristopher Oreilly and Exchange Commission share 1 reportJapanese and Madrid share 1 reportArcotatug Tavatecan and European Society For Medical Oncology share 1 reportEuropean Society For Medical Oncology and Madrid share 1 reportChristopher Oreilly and European Society For Medical Oncology share 1 reportAccess Program and Japanese share 1 reportExchange Commission and Madrid share 1 reportChina and Exchange Commission share 1 reportChina and Madrid share 1 reportChina and Japanese share 1 reportChristopher Oreilly and Japanese share 1 reportAccess Program and Christopher Oreilly share 1 reportEuropean Society For Medical Oncology and Japan share 1 reportChristopher Oreilly and Madrid share 1 reportChina and Japan share 1 reportDocetaxel Monotherapy and Japan share 1 reportDocetaxel Monotherapy and Exchange Commission share 1 reportDocetaxel Monotherapy and European Society For Medical Oncology share 1 reportChina and Christopher Oreilly share 1 reportArcotatug Tavatecan and Docetaxel Monotherapy share 1 reportExchange Commission and Japan share 1 reportArcotatug Tavatecan and Japan share 1 reportArcotatug Tavatecan and Exchange Commission share 1 reportChina and European Society For Medical Oncology share 1 reportAccess Program and Arcotatug Tavatecan share 1 reportDocetaxel Monotherapy and Japanese share 1 reportAccess Program and Docetaxel Monotherapy share 1 reportChristopher Oreilly and Japan share 1 reportExchange Commission and Japanese share 1 reportChina and Docetaxel Monotherapy share 1 reportInternational Normalize…Access ProgramAccess Program - 1 shared report (organization)Arcotatug T…Arcotatug Tavatecan - 1 shared report (person)ChinaChina - 1 shared report (place)Christopher…Christopher Oreilly - 1 shared report (person)Docetaxel M…Docetaxel Monotherapy - 1 shared report (person)European Society …European Society For Medical Oncology - 1 shared report (organization)Exchange Co…Exchange Commission - 1 shared report (organization)JapanJapan - 1 shared report (place)JapaneseJapanese - 1 shared report (place)MadridMadrid - 1 shared report (place)

The stories

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026

74 outlets1 report names International Normalized Ratio5 Aug – 7 Nov

People they appear with

Arcotatug Tavatecan1Christopher Oreilly1Docetaxel Monotherapy1Phuong Khanh1Tsuyoshi Tada1

Places in the same coverage

China1Japan1Japanese1Madrid1Osaka1Spain1

Organisations in the same coverage

Access Program1European Society For Medical Oncology1Exchange Commission1Takeda Pharmaceutical Company Limited Takeda1Takeda Pharmaceuticals1

Who keeps naming them

intelligencer.ca1

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.